Radiation Oncology/Therapy: Page 67

IBA secures FDA clearance for imaging software suite

By AuntMinnieEurope.com staff writers

Radiopharmaceutical provider Ion Beam Applications has received U.S. Food and Drug Administration (FDA) clearance for its adaPT Insight imaging software suite.

November 26, 2013

Nanovi secures funding for radiotherapy marker

By AuntMinnieEurope.com staff writers

Nanovi of Copenhagen, Denmark, has secured funding for its first product: an injectable tissue liquid marker used to improve accuracy in radiation treatment of patients with cancer.

November 21, 2013

BJR: PET/MRI continues to prove its mettle

By Rebekah Moan

Simultaneous PET/MRI has the potential to improve patient care, reduce hospital visits, and provide new and more accurate markers for disease assessment, according to an article published in the British Journal of Radiology. Early proof-of-concept studies show the clinical performance of PET/MRI is on par with PET/CT.

November 21, 2013

IBA closes sale of Cisbio Bioassays

By AuntMinnieEurope.com staff writers

Radiopharmaceutical provider Ion Beam Applications (IBA) has announced the closing of the sale of 100% of its business unit Cisbio Bioassays.

November 18, 2013

Elekta lands large S. Korean rad therapy order

By AuntMinnieEurope.com staff writers

Radiation oncology firm Elekta said that Yonsei University Health System in South Korea has ordered four additional Elekta linear accelerators.

November 18, 2013

IBA reports turnover dip in Q3

By AuntMinnieEurope.com staff writers

Radiopharmaceutical provider Ion Beam Applications (IBA) is reporting a slight drop in turnover for the company's third quarter (end-30 September).

November 12, 2013